Monday, July 14, 2008

TWELVE babies die in Glaxo Vaccine Trials....

At Least 12 Babies Die in Glaxo Vaccine Trials in Argentina

Trading Markets provides news of interest to investors: On July 10, it reported that at least 12 babies, who were test subjects in a clinical trial testing GlaxSmithKline's pneumonia vaccine, in Argentina died. (see below)

According to the Argentine Federation of Health Professionals, or Fesprosa, the pharmaceutical giant uses children from poor families, who are"pressured and forced into signing consent forms. This occurs without anytype of state control" and "does not comply with minimum ethicalrequirements."

Pediatrician Ana Maria Marchese, who works at the children's hospital in the provincial capital where the studies are being conducted, was highly critical: "because they can't experiment in Europe or the UnitedStates, they come to do it in third-world countries."

Indeed, "Colombia and Panama were also chosen by GSK as staging grounds for trials of the vaccine against the pneumococcal bacteria." But one of the lead Glaxo-paid investigators, pediatrician Enrique Smith, is quoted stating: "Only 12 have died throughout the country, which is a very low figure if we compare it with the deaths produced by respiratory illnesses caused by the pneumococcal bacteria."

Since 2007, 15,000 babies have been subjects of the trial, so the death rate in the trial is 1 in 1,250. Question is, would they have died had they received antibiotics and not been in the trial? Fesprosa complained that the parents are pressured, and trial "occurs without any type of control..."If "the trials were authorized when Enrique's brother, Juan Carlos Smith, was provincial health minister" the legitimacy of the trial isquestionable, at best.

The world is bearing witness to the moral dissolution of corporate influenced medicine--a pediatrician is sanguine about the death of 12 babies in a clinical trial, claiming it is "a very low figure..."

This profit-driven culture has derailed medicine from its traditional ethical principles, rapidly converting into a ruthless commercialenterprise.

This medical tragedy is widely disseminated on internet blogs but ignored by the press--Why ????????????????????? Contact: Vera Hassner Sharavveracare@ahrp.org212-595-8974 http://www.tradingmarkets.com/.site/news/Stock%20News/1750553/

No comments: